Literature DB >> 18089851

Activated protein C-cleaved protease activated receptor-1 is retained on the endothelial cell surface even in the presence of thrombin.

Reto A Schuepbach1, Clemens Feistritzer, Lawrence F Brass, Matthias Riewald.   

Abstract

Activated protein C (APC) signals in endothelial cells ex vivo through protease activated receptor-1 (PAR1). However, it is controversial whether PAR1 can mediate APC's protective effects in sepsis because the inflammatory response results in thrombin generation and thrombin proteolytically activates PAR1 much more efficiently than APC. Here we show that APC can induce powerful barrier protective responses in an endothelial cell monolayer in the presence of thrombin. Using cell surface immunoassays with conformation sensitive monoclonal anti-PAR1 antibodies we analyzed cleavage of endogenous PAR1 on the endothelial cell surface by APC in the absence and presence of thrombin. Incubation with APC caused efficient PAR1 cleavage and upon coincubation with thrombin APC supported additional PAR1 cleavage. Thrombin-cleaved PAR1 rapidly disappeared from the cell surface whereas, unexpectedly, the APC-cleaved PAR1 remained and could be detected on the cell surface, even when thrombin at concentrations of up to 1 nM was also present. Our findings demonstrate for the first time directly that APC can generate a distinct PAR1 population on endothelial cells in the presence of thrombin. The data suggest that different trafficking of activated PAR1 might explain how PAR1 signaling by APC can be relevant when thrombin is present.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18089851      PMCID: PMC2254534          DOI: 10.1182/blood-2007-09-113076

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  42 in total

1.  Functional selectivity of G protein signaling by agonist peptides and thrombin for the protease-activated receptor-1.

Authors:  Joseph N McLaughlin; Lixin Shen; Michael Holinstat; Joshua D Brooks; Emmanuele Dibenedetto; Heidi E Hamm
Journal:  J Biol Chem       Date:  2005-05-04       Impact factor: 5.157

Review 2.  The cytoprotective protein C pathway.

Authors:  Laurent O Mosnier; Berislav V Zlokovic; John H Griffin
Journal:  Blood       Date:  2006-11-16       Impact factor: 22.113

3.  Roles of protease-activated receptors in a mouse model of endotoxemia.

Authors:  Eric Camerer; Ivo Cornelissen; Hiroshi Kataoka; Daniel N Duong; Yao-Wu Zheng; Shaun R Coughlin
Journal:  Blood       Date:  2006-01-24       Impact factor: 22.113

4.  Tissue factor deficiency and PAR-1 deficiency are protective against renal ischemia reperfusion injury.

Authors:  Jacob Sevastos; Sean E Kennedy; Darren R Davis; Melissa Sam; Philip W Peake; John A Charlesworth; Nigel Mackman; Jonathan H Erlich
Journal:  Blood       Date:  2006-09-21       Impact factor: 22.113

5.  Protective signaling by activated protein C is mechanistically linked to protein C activation on endothelial cells.

Authors:  Clemens Feistritzer; Reto A Schuepbach; Laurent O Mosnier; Leslie A Bush; Enrico Di Cera; John H Griffin; Matthias Riewald
Journal:  J Biol Chem       Date:  2006-05-18       Impact factor: 5.157

6.  Receptors of the protein C activation and activated protein C signaling pathways are colocalized in lipid rafts of endothelial cells.

Authors:  Jong-Sup Bae; Likui Yang; Alireza R Rezaie
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-13       Impact factor: 11.205

7.  Activated protein C inhibits tissue plasminogen activator-induced brain hemorrhage.

Authors:  Tong Cheng; Anthony L Petraglia; Zhang Li; Meenakshisundaram Thiyagarajan; Zhihui Zhong; Zhenhua Wu; Dong Liu; Sanjay B Maggirwar; Rashid Deane; José A Fernández; Barbra LaRue; John H Griffin; Michael Chopp; Berislav V Zlokovic
Journal:  Nat Med       Date:  2006-10-29       Impact factor: 53.440

8.  Role of tissue factor and protease-activated receptors in a mouse model of endotoxemia.

Authors:  Rafal Pawlinski; Brian Pedersen; Gernot Schabbauer; Michael Tencati; Todd Holscher; William Boisvert; Patricia Andrade-Gordon; Rolf Dario Frank; Nigel Mackman
Journal:  Blood       Date:  2003-10-23       Impact factor: 22.113

9.  Protease-activated receptor 1 mediates thrombin-dependent, cell-mediated renal inflammation in crescentic glomerulonephritis.

Authors:  M A Cunningham; E Rondeau; X Chen; S R Coughlin; S R Holdsworth; P G Tipping
Journal:  J Exp Med       Date:  2000-02-07       Impact factor: 14.307

10.  Endotoxemia and sepsis mortality reduction by non-anticoagulant activated protein C.

Authors:  Edward J Kerschen; José A Fernandez; Brian C Cooley; Xia V Yang; Rashmi Sood; Laurent O Mosnier; Francis J Castellino; Nigel Mackman; John H Griffin; Hartmut Weiler
Journal:  J Exp Med       Date:  2007-09-24       Impact factor: 14.307

View more
  38 in total

1.  The efficacy of activated protein C in murine endotoxemia is dependent on integrin CD11b.

Authors:  Chunzhang Cao; Yamei Gao; Yang Li; Toni M Antalis; Francis J Castellino; Li Zhang
Journal:  J Clin Invest       Date:  2010-05-10       Impact factor: 14.808

2.  Kallikrein 6 is a novel molecular trigger of reactive astrogliosis.

Authors:  Isobel A Scarisbrick; Maja Radulovic; Joshua E Burda; Nadya Larson; Sachiko I Blaber; Caterina Giannini; Michael Blaber; Alexander G Vandell
Journal:  Biol Chem       Date:  2012-04       Impact factor: 3.915

Review 3.  Signal transduction by protease-activated receptors.

Authors:  Unice J K Soh; Michael R Dores; Buxin Chen; JoAnn Trejo
Journal:  Br J Pharmacol       Date:  2010-05       Impact factor: 8.739

Review 4.  New insights into modulation of thrombin formation.

Authors:  Henri M H Spronk; Julian I Borissoff; Hugo ten Cate
Journal:  Curr Atheroscler Rep       Date:  2013-11       Impact factor: 5.113

Review 5.  Biased signalling and proteinase-activated receptors (PARs): targeting inflammatory disease.

Authors:  M D Hollenberg; K Mihara; D Polley; J Y Suen; A Han; D P Fairlie; R Ramachandran
Journal:  Br J Pharmacol       Date:  2014-03       Impact factor: 8.739

Review 6.  Activated protein C: biased for translation.

Authors:  John H Griffin; Berislav V Zlokovic; Laurent O Mosnier
Journal:  Blood       Date:  2015-03-30       Impact factor: 22.113

Review 7.  Protease-activated receptor signalling by coagulation proteases in endothelial cells.

Authors:  Alireza R Rezaie
Journal:  Thromb Haemost       Date:  2014-07-03       Impact factor: 5.249

Review 8.  Mechanisms of anticoagulant and cytoprotective actions of the protein C pathway.

Authors:  E A M Bouwens; F Stavenuiter; L O Mosnier
Journal:  J Thromb Haemost       Date:  2013-06       Impact factor: 5.824

9.  Protection of vascular barrier integrity by activated protein C in murine models depends on protease-activated receptor-1.

Authors:  Reto A Schuepbach; Clemens Feistritzer; José A Fernández; John H Griffin; Matthias Riewald
Journal:  Thromb Haemost       Date:  2009-04       Impact factor: 5.249

10.  Growing insights into the potential benefits and risks of activated protein C administration in sepsis: a review of preclinical and clinical studies.

Authors:  Laith Altaweel; Daniel Sweeney; Xizhong Cui; Amisha Barochia; Charles Natanson; Peter Q Eichacker
Journal:  Biologics       Date:  2009-09-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.